Current Assets
Inventories
Bristol-Myers Squibb Inventories decreased by 2.5% to $2.69B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.2%, from $2.56B to $2.69B. Over 5 years (FY 2020 to FY 2025), Inventories shows an upward trend with a 5.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase might suggest overproduction or weakening demand, while a decrease could indicate strong sales or potential supply chain shortages.
Detailed definition
The carrying value of raw materials, work-in-process, and finished goods awaiting sale to consumers or enterprise client...
Peer comparison
Consumer electronics firms strive for high inventory turnover to mitigate the risk of rapid technological depreciation.
Metric ID:
inventoriesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $876.00M | $774.00M | $2.10B | $843.00M | $661.00M | $599.00M | $2.34B | $523.00M | $720.00M | $847.00M | $2.66B | $2.99B | $3.08B | $3.33B | $2.56B | $2.67B | $2.74B | $2.76B | $2.69B |
| QoQ Change | — | -11.6% | +170.7% | -59.8% | -21.6% | -9.4% | +290.5% | -77.6% | +37.7% | +17.6% | +214.3% | +12.1% | +3.1% | +8.3% | -23.3% | +4.3% | +2.7% | +0.8% | -2.5% |
| YoY Change | — | — | — | — | -24.5% | -22.6% | +11.6% | -38.0% | +8.9% | +41.4% | +13.8% | +470.7% | +327.4% | +293.4% | -3.9% | -10.7% | -11.0% | -17.2% | +5.2% |
Range$523.00M – $3.33B
CAGR+28.3%
Avg YoY Growth+69.6%
Median YoY Growth+5.2%
Inventories at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's inventories?
- Bristol-Myers Squibb (BMY) reported inventories of $2.69B in Q4 2025.
- How has Bristol-Myers Squibb's inventories changed year-over-year?
- Bristol-Myers Squibb's inventories increased by 5.2% year-over-year, from $2.56B to $2.69B.
- What is the long-term trend for Bristol-Myers Squibb's inventories?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's inventories has grown at a 5.3% compound annual growth rate (CAGR), from $2.07B to $2.69B.
- What does inventories mean?
- The value of products currently being manufactured or held in stock ready to be sold.